News
Some health experts view GLP-1s as a promising option for PCOS, which lacks a standard treatment and affects millions of ...
Eli Lilly and Company (NYSE:LLY) is one of the best long term low volatility stocks to buy now. In a report released on July ...
Novo Nordisk sees solid Q1 results, major GLP-1 growth potential, and limited downside despite guidance cut and rising risks.
President Trump is pushing drugmakers to move production back to the United States. He's upping the ante with tariffs to encourage the shift. But would tariffs on imported drugs be enough?
Daniel Drucker, Ozempic’s father: ‘I’m very conservative. I don’t sell the drugs. I study the drugs’
The Canadian researcher has just received the Frontiers of Knowledge Award for his work on anti-obesity drugs. However, he ...
Evidence suggests drugmakers manipulated trials and government failed to respond while patients live with permanent loss of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results